Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Bone Metastases × Denosumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Giant Cell Tumor of Bone 2 Thyroid Cancer Metastatic 1 Osteoporotic Fractures 1 Osteoporosis 1 Osteoblastoma 1 Neoplasm Metastasis 1 Musculoskeletal Pain 1 Melanoma 1 Kidney Neoplasms 1 Granuloma, Giant Cell 1 Chondroblastoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Bone Metastasis From Solid Tumors 1 Bone Metastases From Solid Tumors 1 Bone Metastases 1 Bone Cysts, Aneurysmal 1 Arthralgia 1

Interventions

QL1206 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04550949 2020-09-22

To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 3 Unknown

Bone Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡